Get started
Author

Christine E. Engeland

Observed names: C E Engeland, C.E. Engeland, Christine E Engeland, Christine Engeland, E. Engeland, Christine, Engeland, Christine, Engeland, Christine E.
Observed institutions: Witten/Herdecke University, German Cancer Research Center, Heidelberg University, University Hospital Heidelberg, National Center for Tumor Diseases, University Hospital Leipzig, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig University
ORCID: 0000-0001-6032-8786
Observed ORCID: 0000-0001-6032-8786
OpenAlex ID: A5050832985
CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
2014 · Christine E Engeland, Christian Grossardt, et al. · Molecular Therapy · 283
PDF
Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies
2021 · Johannes P. W. Heidbuechel, Christine E. Engeland · Journal of Hematology & Oncology · 111
Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors
2018 · Tobias Speck, Johannes P.W. Heidbuechel, et al. · Clinical Cancer Research · 106
Measles Virus as an Oncolytic Immunotherapy
2021 · Christine E. Engeland, Guy Ungerechts · Cancers · 95
PDF
Granulocyte-Macrophage Colony-Stimulating Factor-Armed Oncolytic Measles Virus Is an Effective Therapeutic Cancer Vaccine
2013 · Christian Grossardt, Christine E. Engeland, et al. · Human Gene Therapy · 94
Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation
2017 · Rūta Veinalde, Christian Grossardt, et al. · OncoImmunology · 79
PDF
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
2014 · M A Baertsch, M F Leber, et al. · Cancer Gene Therapy · 61
Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
2019 · Johanna Reul, Janina Frisch, et al. · Frontiers in Oncology · 57
PDF
Proteome analysis of the HIV-1 Gag interactome
2014 · Christine E. Engeland, Nigel P. Brown, et al. · Virology · 54
PDF
Mechanisms of measles virus oncolytic immunotherapy
2020 · Gemma Pidelaserra-Martí, Christine E. Engeland · Cytokine & Growth Factor Reviews · 53
PDF
Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
2021 · Jacek Hajda, Barbara Leuchs, et al. · Clinical Cancer Research · 46
A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol
2017 · Jacek Hajda, Monika Lehmann, et al. · BMC Cancer · 45
PDF
Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists
2019 · Paul S. Backhaus, Rūta Veinalde, et al. · Viruses · 43
PDF
Advances in oncolytic virotherapy
2022 · Stephen J. Russell, John C. Bell, et al. · Communications Medicine · 41
PDF
Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites
2018 · Mathias Felix Leber, Marc-Andrea Baertsch, et al. · Molecular Therapy — Oncolytics · 37
PDF
Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer cultures
2024 · Theresa E. Schäfer, Lisanne I. Knol, et al. · EBioMedicine · 34
Fighting Cancer with Mathematics and Viruses
2017 · Daniel Santiago, Johannes Heidbuechel, et al. · Viruses · 34
Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
2021 · Dirk M. Nettelbeck, Mathias F. Leber, et al. · Viruses · 31
PDF
Introduction to Oncolytic Virotherapy
2019 · Christine E. Engeland, John C. Bell · Methods in molecular biology · 30
The Cellular Protein Lyric Interacts with HIV-1 Gag
2011 · Christine E. Engeland, Heike Oberwinkler, et al. · Journal of Virology · 26
Virotherapy Research in Germany: From Engineering to Translation
2017 · Guy Ungerechts, Christine E. Engeland, et al. · Human Gene Therapy · 23
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer
2021 · Hans Martin Singh, Mathias Felix Leber, et al. · Molecular Therapy — Oncolytics · 22
PDF
Measles Vaccines Designed for Enhanced CD8+ T Cell Activation
2020 · Elena Busch, Kristina D. Kubon, et al. · Viruses · 19
PDF
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
2021 · Rūta Veinalde, Gemma Pidelaserra-Martí, et al. · Molecular Therapy — Oncolytics · 18
PDF
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
2019 · Johannes P.W. Heidbuechel, Christine E. Engeland · Journal of Visualized Experiments · 17
Works count: 70
Citation count: 1,566
H-index: 22
I10-index: 31
Year
Topic
Type